[1] 罗清礼.甲状腺相关眼病[M].北京:人民卫生出版社,2005:54-61.
[2] Nygaard B,Hegedus L,Gervil M,et al. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease[J]. J Intern Med, 1995,238(6):491-497.
[3] Sridama V, McCormick M, Kaplan EL, et al. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease[J]. N Engl J Med, 1984,311(7):426-432.
[4] Cohen-Lehman J, Dahl P, Danzi S, et al. Effects of amiodarone therapy on thyroid function[J]. Nat Rev Endocrinol, 2010,6:34.
[5] Eskes SA, Wiersinga WM. Amiodarone and thyroid[J]. Best Pract Res Clin Endocrinol Metab, 2009,23(6):735-751.
[6] 陈雪梅,刘皴力,范 源,等. 碘过量与桥本氏甲状腺炎之间关系的研究进展[J]. 昆明医科大学学报,2014,35(12):169-174.
[7] Teng X, Shan Z, Teng W.et al.Experimental study on the effects of chronic iodine excess on thyroid function,structure,and auto immunity in auto immune-prone NODH-2h4 mice[J].Clin Exp Med,2009,9(1):51-59.
[8] Pramyothin P, Leung AM, Pearce EN,et al.Clinical problem-solving.A hidden solution[J].N Engl J Med,2011,365:2123-2127.
[9] 黄 琨,刘品明,张少玲.胺碘酮与甲状腺功能异常[J].岭南急诊医学杂志,2014,19(2):161-163.
[10] 任志强. 72例胺碘酮治疗心律失常致甲状腺功能减退临床分析[J].中国实用医药,2015,10(29):150-151.
[11] 乔庆红,傅 颖,张 柱,等.慢性心衰合并甲状腺功能减退症的治疗分析[J].中国社区医药,2015,31(6):17-19.
[12] 邓世斌. 心律失常患者服用胺碘酮引起甲状腺功能减退的临床分析[J].现代诊断与治疗,2015,26(3):606-607.